What is she best known for?
The fields of study she is best known for:
- Dopamine
- Internal medicine
- Psychiatry
Maria L. Carlsson mostly deals with Dopamine, Neuroscience, Psychosis, Schizophrenia and Neurotransmitter.
As part of her Endocrinology and Internal medicine and Dopamine studies, she is studying Dopamine.
Her study explores the link between Neuroscience and topics such as Glutamatergic that cross with problems in Neurotransmission, Cerebral cortex and Monoaminergic.
In her study, Pharmacology is inextricably linked to Basal ganglia, which falls within the broad field of Monoaminergic.
Her Psychosis research integrates issues from Dopamine receptor, Dopamine receptor D2, Dopamine receptor D3, Endogenous agonist and Dopamine agonist.
Many of her studies involve connections with topics such as Glutamate receptor and Neurotransmitter.
Her most cited work include:
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease (1022 citations)
- Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence (604 citations)
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice (395 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Internal medicine, Endocrinology, Dopamine, Pharmacology and Agonist.
Her work deals with themes such as NMDA receptor, Receptor and Serotonin, which intersect with Endocrinology.
Her NMDA receptor study incorporates themes from Monoamine neurotransmitter and Antagonist.
Her Dopamine study integrates concerns from other disciplines, such as Autoreceptor and Neurotransmitter.
Maria L. Carlsson has included themes like Dizocilpine, Dopamine receptor D2, Haloperidol and Partial agonist in her Pharmacology study.
Her Neuroscience research is multidisciplinary, relying on both Glutamate receptor, Glutamatergic and Schizophrenia.
She most often published in these fields:
- Internal medicine (49.35%)
- Endocrinology (42.86%)
- Dopamine (41.56%)
What were the highlights of her more recent work (between 2012-2021)?
- Internal medicine (49.35%)
- Beck Depression Inventory (6.49%)
- Adverse effect (5.19%)
In recent papers she was focusing on the following fields of study:
Maria L. Carlsson spends much of her time researching Internal medicine, Beck Depression Inventory, Adverse effect, Tolerability and Randomized controlled trial.
Her Internal medicine research is multidisciplinary, incorporating elements of Occipital lobe and Endocrinology.
The concepts of her Adverse effect study are interwoven with issues in Therapeutic effect and Physical therapy.
The study incorporates disciplines such as COPD, Pulmonary function testing and Cardiology in addition to Physical therapy.
Her study in Randomized controlled trial is interdisciplinary in nature, drawing from both Intervention, Psychiatry, Anesthesia and Cardiac surgery.
Her research in Caudate nucleus intersects with topics in Gyrus, Choline, Thalamus, Gastroenterology and Sulcus.
Between 2012 and 2021, her most popular works were:
- Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over study. (20 citations)
- The Dopamine Stabilizer (−)-OSU6162 Occupies a Subpopulation of Striatal Dopamine D2/D3 Receptors: An [ 11 C]Raclopride PET Study in Healthy Human Subjects (18 citations)
- A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome. (10 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Dopamine
Her primary scientific interests are in Internal medicine, Beck Depression Inventory, Randomized controlled trial, Depression and Concomitant.
Her Internal medicine study combines topics in areas such as Endocrinology and Mood.
Her Raclopride, Caudate nucleus, Dopamine receptor D2, Putamen and Ventral striatum study are her primary interests in Endocrinology.
Her research on Raclopride is centered around Dopamine and Striatum.
Her work carried out in the field of Mood brings together such families of science as Tolerability and Adverse effect.
Her Depression research integrates issues from Stroke and Chronic fatigue syndrome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
